Gemma Broughall

Gemma is a senior associate in the Disputes & Investigations group. She has experience in a broad range of complex corporate and commercial matters, in both the High Court and international arbitration. Gemma has particular experience in relation to high value professional negligence disputes and regulatory claims for accountancy clients.

Show full CV Hide full CV

Career

Since 2022	Senior associate, Taylor Wessing
2018 - 2022	Associate, Taylor Wessing
2013 - 2018	Contract lawyer, Taylor Wessing

2012 - 2013	Contract lawyer, Macfarlanes
2011 - 2012	Trainee, Orrick, Herrington & Sutcliffe
2007 - 2011	Paralegal, Orrick Rambaud Martel, Paris

More Less

Education

2012	Admitted as a lawyer, England & Wales
2005	Legal Practice Certificate (Distinction), BPP Law School
2004	Postgraduate Diploma, BPP Law School

1999

Bachelors, French and Italian, University of Exeter

More Less

Additional languages

English

Expertise

Sectors Business & professional services

Experience

Patisserie Holdings plc	Acting on auditor claims for some £200 million, and associated regulatory and criminal proceedings, relating to the collapse of the Patisserie Valerie chain
Manchester Building Society v Grant Thornton UK LLP	Defence of a c.£50 million audit negligence claim relating to losses arising on interest rate swap contracts.
Representing a Middle Eastern satellite provider	Representing a Middle Eastern satellite provider in relation to multiple arbitration proceedings under the LCIA and SIAC rules concerning licence agreement terminations.

Defence of a claim for GBP1.6 billion	PwC in defending a claim for GBP1.6 billion arising out of the collapse of the sub-prime lender, Cattles plc and its trading subsidiary, Welcome Financial Services Ltd, following the discovery of a shortfall in its bad debt provision.
Financial Institutions	A leading firm of accountants in relation to a claim for professional negligence made against it in the High Court.
Acting on a multi-million pound arbitration claim	A medical research organisation in a multi-million pound arbitration claim against a Japanese pharmaceutical company, seeking royalties due on the sales of a blockbuster drug resulting from an R&D collaboration between the parties.